Faculty Information - 村上　てるみ

（Last updated : 2024-03-05 10:39:26）

村上　てるみ
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Pediatrics

Position Assistant Professor

■ Books

Chapter contribution　

Segawa disease (deficiency of GTP cyclohydrolase I)「今日の神経疾患治療指針」 2013/03/15

■ Published papers

1.	Case report	GNAO1-Related Disorder in a Patient with Psychomotor Developmental Delay and Hypotonia 2022/04/25
2.	Original article	Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy. 2021/12/20
3.	Review article	A short form of gross motor function measure for Fukuyama congenital muscular dystrophy 2020/05
4.	Original article	Characteristic findings of skeletal muscle MRI in caveolinopathies. 2018/10
5.	Case report	National registry of patients with Fukuyama congenital muscular dystrophy in Japan. 2018/10
6.	Original article	Respiratory management of patients with Fukuyama congenital muscular dystrophy. 2016/03
7.	Case report	Different Responses to Enzyme Replacement Therapy in Two Patients with Childhood-onset Pompe Disease 2013/01
8.	Original article	Identification of a Duplication Breakpoint in the DMD Gene Using Array Comparative Genomic Hybridization 2013/01
9.	Original article	Insomnia in Patients with Fukuyama Congenital Muscular Dystrophy 2013/01
10.	Original article	Long-term and Low-dose Steroid Therapy for Cardiomyopathy in Duchenne Muscular Dystrophy Patients 2013/01
11.	Original article	Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy. 2012/04
12.	Original article	Close monitoring of initial enzyme replacement therapy in a patient with childhood-onset Pompe disease 2012/02
13.	Original article	High-density CT of muscle and liver may allow early diagnosis of childhood-onset Pompe disease 2012/02
14.	Original article	High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation. 2010/10
15.	Original article	Benefits of FK 506 for refractory eye symptoms in a young child with ocular myasthenia gravis 2009/09
16.	Original article	A novel POMT2 mutation causes mild congenital muscular dystrophy with normal brain MRI 2009/06
Display 5 items
Display all(16)

■ Academic conference presentation

1.	Study of dysphagia in Fukuyama congenital muscular dystrophy (FCMD) 2023/10/06
2.	Sleep disorders in Fukuyama congenital muscular distrophy 2023/05/27
3.	Study of dysphagia in Fukoyama congenital muscular dystrophy (FCMD) 2023/05/27
4.	Long-term follow-up of skeletal muscle imaging in patients with childhood-onset Pompe disease 2023/05/26
5.	Evaluation of essential trace elements in patients with Fukuyama congenital muscle dystrophy 2023/04/16
6.	Characteristics of cardiac dysfunction in patients with Fukuyama congenital muscular dystrophy 2022/10/14
7.	Characteristics of cardiac dysfunction in patients with Fukuyama congenital muscular dystrophy 2022/06/03
8.	Correlation between BNP and NT-proBNP in muscular dystrophy (Second report) 2022/06/03
9.	Family association questionnaire on "unmanageable troubled behaviors” in patients with FCMD 2022/06/03
10.	A symptomatic female MTM1 mutation carrier with right-dominant asymmetric muscle weakness 2021/05/29
11.	Correlation between BNP and NT-proBNP in muscular dystrophy 2021/05/28
12.	Evaluation of essential trace elements in patients with Fukuyama congenital muscle dystrophy 2021/05/28
13.	Recommendations for futurebpediatricians ~Diversifying needs for pediatricians 2021/04/16
14.	Actigraphy is valid for motor function assessment of Fukuyama congenital muscular dystrophy 2020/08/19
15.	Efficacy evaluation of Nusinersen for spinal muscular atrophy type 1/2 using bioelectrical impedance 2020/08/19
16.	Complications of Fukuyama congenital muscular dystrophy revealed from a nationwide registry 2019/10/04
17.	Urinary titin fragment in Fukuyama congenital muscular dystrophy 2019/10/04
18.	Characteristic findings of skeletal muscle MRI in Cavecolinopathies 2019/10/02
19.	Characteristic skeletal muscle imuscle imaging patterns in Japanese patients with Pompe disease 2019/07/13
20.	Characteristic findings of skeletal muscle MRI in childhood-onset Cavecolinopathy 2019/06/01
21.	Efficacy of corticosteroids therapy for Fukuyama congenital muscular dystrophy 2019/05/31
22.	Urinary titin fragment in Fukuyama congenital muscular dystrophy 2019/05/31
23.	Care and prevention of foot disorders in Bethelm myopathy patients 2018/06/01
24.	Modified gross motor function measure for Fukuyama congenital muscular dystrophy 2018/05/31
25.	Time-dependent change of Musce MRI STIR in Fukuyama congenital muscular dystrophy 2017/10/14
26.	A Japanese nationwide survey on congenital myotonic dystrophy 2017/05/13
27.	Relationship between inpedance obtained by BIA and MR Images of limbs of patients with Fukuyama congenital muscular dystrophy 2017/05/13
28.	The gross motor function measure is valid for Fukuyama congenital muscular dystrophy 2017/05/13
29.	Correlation between MRI STIR image of lower limbs and BIA in the natural course of FCMD patients 2016/06/03
30.	Nationwide patient registry of Fukuyama congenital muscular dystrophy in Japan 2016/06/03
31.	Our approach which aimed at ideal transition for muscular dystrophy patients to adult health care 2016/06/03
32.	The gross motor function measure is a valid for Fukuyama congenital muscular dystrophy 2016/06/03
33.	Time-dependent change of Muscle MRI STIR in Fukuyama congenital muscular dystrophy 2016/06/03
34.	Effectiveness of levetiracetam for seizures in patients with Fukuyama congenital muscular dystrophy 2014/10/09
35.	Natural history of motor function in patients with Fukuyama congenital muscular dystrophy 2014/10/09
36.	Renal dysfunction in patients with Fukuyama congenital muscular dystrophy 2014/10/09
37.	A new index of muscle development and disease progression for the pediatric patients with Duchenne muscular dystrophy, using bioelectrical impedance analysis: An observation study 2014/10/08
38.	A new index of muscle development and disease progression for the pediatric patients with Fukuyama congenital muscular dystrophy, using bioelectrical impedance analysis; an observation study 2014/10/08
39.	Skeletal muscle MRI in an X-linked myotubular myopathy patient who became ambulatory 2014/10/07
40.	Skeletal muscle MRI with fat suppression technique can detect early changes in childhood onset Pompe disease in patients receiving ERT 2014/09/27
41.	Chronic respiratory failure in patients with Fukuyama congenital muscular dystrophy 2013/10/02
42.	Steroid Treatment for exacerbation of muscle weakness after viral infection in Fukuyama congenital muscular dystrophy 2013/10/02
43.	Therapeutic intervention for dysphagia in patients with Fukuyama congenital muscular dystrophy 2013/10/02
44.	Low-dose steroid therapy for cardiomyopathy in Duchenne Muscular Dystrophy patients 2012/10/09
45.	Scoliosis in Fukuyama congenital muscular dystrophy(FCMD) patients 2012/10/09
46.	Early progression of respiratory failure in a young firl with autosomal dominant Emery-Dreifuss muscular dystrophy. 2012/09/07
47.	Skeleta muscle images in childhood-onset Pompe disease patients receiving enzyme replacement therapy (ERT) 2012/09/07
48.	Efficacy of low-dose steroid therapy for scoliosis in patients with Duchenne muscular dystrophy 2011/10/21
49.	Longitudinal study of skeletal muscle images in childhood-onset Pompe disease patients receiving enzyme replacement therapy(ERT) 2011/10/20
50.	Early progression of respiratory failure in a young firl with autosomal dominant Emery-Dreifuss muscular dystrophy. 2011/09/07
51.	Selection of isotonic saline as initial parenteral fluid therapy for children with either of high fever, vomiting and dyspnea 2011/06/02
52.	Two Japanese girls with juvenile-onset tumefactive multiple sclerosis 2011/05/13
53.	High density of skeletal muscle CT imaging indicates accumulation of calcium in autophagic vacules in childhood-onset Pompe disease 2010/11/19
54.	High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation 2010/10/23
55.	Severe muscle damage following viral infection in patients with Fukuyama congental muscular dystrophy 2010/10/23
56.	Cardiopathy form of α-dystroglycanopathy caused by FKTN mutation in Japan 2010/10/12
57.	Clinical and electroencephalographic analysis in patients with Fukuyama congenital muscular dystrophy 2010/10/12
58.	Severe muscle damage following viral infection in patients with Fukuyama type congenital muscular dystrophy(FCMD) 2010/10/12
59.	Specific finding of high-density changes on skeletal muscle CT scan in childhood-onset Pompe disease 2009/09/25
60.	High density on skeletal muscle CT imaging indicates accumulation of calcium in autophagic vacuoles in childhood-onset Pompe disease 2009/09/10
61.	Cardiac complication in LGMD 2L 2007/12/15
62.	Congenital myasthenic syndrome in Japan 2007/12/15
63.	Fukuyama congenital muscular dystrophy: Rhabdomyolysis induced by viral infection. 2007/12/15
64.	initial efficacy of enzyme replacement therapy for a patient with childhood-onset Pompe disease 2007/11/29
65.	The utility of skeletal muscle CT scan in childhood-onset Pompe disease 2007/10/18
66.	Fukutin Gene Mutations Can Cause Familial Dilated Cardiomyopathy with Minimal Muscle Weakness and Normal Intelligence 2007/01/24
67.	The First Japanese Patient with Congenital Myasthenic Syndrome with Acetylcholine Receptor Deficiency 2007/01/24
68.	α-dystroglycanopathy in Japan 2005/09/28
Display 5 items
Display all(68)

■ Education

1.	1995/04～2001/03	Faculty of Medicine, Tokyo Women's Medical University, Completed,
2.	2003/04～2007/03	〔Doctoral course〕, Graduate School, Division of Medicine, Tokyo Women's Medical University, Completed,